Evidence map›Paper›PMID 26313266›Full record

ArticlePloS one2015

CP-154,526 Modifies CREB Phosphorylation and Thioredoxin-1 Expression in the Dentate Gyrus following Morphine-Induced Conditioned Place Preference.

Juan-Antonio García-Carmona, Daymi M Camejo, Pilar Almela, Ana Jiménez, María-Victoria Milanés, Francisca Sevilla, María-Luisa Laorden

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Juan-Antonio García-CarmonaDepartment of Pharmacology, Faculty of Medicine, University of Murcia, Murcia, Spain.
Daymi M CamejoDepartment of Stress Biology and Plant Pathology, CEBAS-CSIC, Murcia, Spain.
Pilar AlmelaDepartment of Pharmacology, Faculty of Medicine, University of Murcia, Murcia, Spain.
Ana JiménezDepartment of Stress Biology and Plant Pathology, CEBAS-CSIC, Murcia, Spain.
María-Victoria MilanésDepartment of Pharmacology, Faculty of Medicine, University of Murcia, Murcia, Spain.
Francisca SevillaDepartment of Stress Biology and Plant Pathology, CEBAS-CSIC, Murcia, Spain.
María-Luisa LaordenDepartment of Pharmacology, Faculty of Medicine, University of Murcia, Murcia, Spain.
Universidad de Murcia · ESCentro de Edafología y Biología Aplicada del Segura · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Corticotropin-releasing factor (CRF) acts as neuro-regulator of the behavioral and emotional integration of environmental and endogenous stimuli associated with drug dependence. Thioredoxin-1 (Trx-1) is a functional protein controlling the redox status of several proteins, which is involved in addictive processes. In the present study, we have evaluated the role of CRF1 receptor (CRF1R) in the rewarding properties of morphine by using the conditioned place preference (CPP) paradigm. We also investigate the effects of the CRF1R antagonist, CP-154,526, on the morphine CPP-induced activation of CRF neurons, CREB phosphorylation and Trx expression in paraventricular nucleus (PVN) and dentate gyrus (DG) of the mice brain. CP-154,526 abolished the acquisition of morphine CPP and the increase of CRF/pCREB positive neurons in PVN. Moreover, this CRF1R antagonist prevented morphine-induced CRF-immunoreactive fibers in DG, as well as the increase in pCREB expression in both the PVN and DG. In addition, morphine exposure induced an increase in Trx-1 expression in DG without any alterations in PVN. We also observed that the majority of pCREB positive neurons in DG co-expressed Trx-1, suggesting that Trx-1 could activate CREB in the DG, a brain region involved in memory consolidation. Altogether, these results support the idea that CRF1R antagonist blocked Trx-1 expression and pCREB/Trx-1 co-localization, indicating a critical role of CRF, through CRF1R, in molecular changes involved in morphine associated behaviors.

Indexed as

AnimalsBlotting, WesternCells, CulturedConditioning, PsychologicalCRF Receptor, Type 1Cyclic AMP Response Element-Binding ProteinDentate GyrusFluorescent Antibody TechniqueImmunoenzyme TechniquesMaleMiceMorphineMorphine DependenceNarcoticsNeuronsPhosphorylationCP 154526Creb1 protein, mouseCRF Receptor, Type 1Cyclic AMP Response Element-Binding ProteinMorphineNarcoticsPyrimidinesPyrrolesReceptors, Corticotropin-Releasing HormoneThioredoxinsTxn1 protein, mouse

Identifiers

PMID26313266
PMCPMC4551807
OpenAlexW1895612863

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.